DE69738600D1 - Neuroaktive peptide - Google Patents

Neuroaktive peptide

Info

Publication number
DE69738600D1
DE69738600D1 DE69738600T DE69738600T DE69738600D1 DE 69738600 D1 DE69738600 D1 DE 69738600D1 DE 69738600 T DE69738600 T DE 69738600T DE 69738600 T DE69738600 T DE 69738600T DE 69738600 D1 DE69738600 D1 DE 69738600D1
Authority
DE
Germany
Prior art keywords
neuroactive peptides
val
neuroactive
peptides
angiotensin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69738600T
Other languages
English (en)
Other versions
DE69738600T2 (de
Inventor
Frederick A Mendelsohn
Siew Yeen Chai
Ingrid Moeller
Peter G Aldred
Ian A Smith
Rebecca A Lew
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Florey Institute of Neuroscience and Mental Health
Original Assignee
Howard Florey Institute of Experimental Physiology and Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Howard Florey Institute of Experimental Physiology and Medicine filed Critical Howard Florey Institute of Experimental Physiology and Medicine
Publication of DE69738600D1 publication Critical patent/DE69738600D1/de
Application granted granted Critical
Publication of DE69738600T2 publication Critical patent/DE69738600T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE69738600T 1996-07-09 1997-07-09 Neuroaktive peptide Expired - Lifetime DE69738600T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO089396 1996-07-09
AUPO0893A AUPO089396A0 (en) 1996-07-09 1996-07-09 Neuroactive peptide
PCT/AU1997/000436 WO1998001465A1 (en) 1996-07-09 1997-07-09 Neuroactive peptide

Publications (2)

Publication Number Publication Date
DE69738600D1 true DE69738600D1 (de) 2008-05-08
DE69738600T2 DE69738600T2 (de) 2009-07-23

Family

ID=3795208

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69738600T Expired - Lifetime DE69738600T2 (de) 1996-07-09 1997-07-09 Neuroaktive peptide

Country Status (9)

Country Link
US (1) US7026280B2 (de)
EP (1) EP0917535B1 (de)
JP (1) JP4275738B2 (de)
AT (1) ATE390440T1 (de)
AU (1) AUPO089396A0 (de)
CA (1) CA2259137A1 (de)
DE (1) DE69738600T2 (de)
NZ (1) NZ333632A (de)
WO (1) WO1998001465A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005508882A (ja) * 2001-08-02 2005-04-07 ホワード フローリー インスティチュート オブ エクスペリメンタル フィジオロジー アンド メディシン インスリン調節アミノペプチダーゼ（ｉｒａｐ）／アンギオテンシンｉｖ（ａｔ４）受容体活性の調節
EG23584A (en) * 2003-11-11 2006-09-11 Ali Mokhtar Al-Hossary Amr Elimination of myoglobin from blood using an i v filter
CA2619481A1 (en) * 2005-08-23 2007-03-01 Wyeth Methods for the treatment of anxiety and for identification of anxiolytic agents
US9066901B2 (en) * 2006-07-07 2015-06-30 Washington State University C-Met receptor regulation by angiotensin IV (AT4) receptor ligands
US9732074B2 (en) 2013-03-15 2017-08-15 University Of Southern California Methods, compounds, and compositions for the treatment of angiotensin-related diseases
EP2968441A1 (de) 2013-03-15 2016-01-20 University of Southern California Verfahren zur behandlung von multipler sklerose
RU2727167C1 (ru) * 2019-09-17 2020-07-21 Общество С Ограниченной Ответственностью "Герофарм" Композиция полипептидов, обладающая свойством нормализовать функции головного мозга
RU2727162C1 (ru) * 2019-09-17 2020-07-21 Общество С Ограниченной Ответственностью "Герофарм" Композиция полипептидов, обладающая свойством нормализовать функции головного мозга

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5063206A (en) * 1988-12-16 1991-11-05 The United States Of Americas As Represented By The Department Of Health And Human Services Compositions having use as treatment of neuropsychiatric deficits
US5599907A (en) * 1989-05-10 1997-02-04 Somatogen, Inc. Production and use of multimeric hemoglobins
US5861483A (en) * 1996-04-03 1999-01-19 Pro-Neuron, Inc. Inhibitor of stem cell proliferation and uses thereof

Also Published As

Publication number Publication date
ATE390440T1 (de) 2008-04-15
JP2001504803A (ja) 2001-04-10
EP0917535B1 (de) 2008-03-26
EP0917535A4 (de) 2001-11-21
WO1998001465A1 (en) 1998-01-15
CA2259137A1 (en) 1998-01-15
JP4275738B2 (ja) 2009-06-10
US20020147129A1 (en) 2002-10-10
EP0917535A1 (de) 1999-05-26
AUPO089396A0 (en) 1996-08-01
US7026280B2 (en) 2006-04-11
DE69738600T2 (de) 2009-07-23
NZ333632A (en) 2000-06-23

Similar Documents

Publication Publication Date Title
HUP0300246A2 (en) Delivery system
NZ263344A (en) Human bactericidal/permeability increasing (bpi) protein functional domain peptides and their use
CA2181150A1 (en) Biologically Active Peptides from Functional Domains of Bactericidal/Permeability-Increasing Protein and Uses Thereof
DE69833948D1 (de) Aktives system zur frühen zerstörung von schleppwirbeln
ATE410441T1 (de) Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidinanalogen
DE69703449D1 (de) Neuroaktive peptide
ID24520A (id) Analog-analog peptida lh-rh, penggunaannya dan komposisi farmasi yamg mengandungnya
DE69533704D1 (de) Bradykinin-antagonist peptide mit n-substituierten glycinen
PT896615E (pt) Peptido proveniente de uma forma soluvel de acetilcolinesterase activo como modulador dos canais de calcio
BR9813817A (pt) Análogos de hemiasterlina
DE69738600D1 (de) Neuroaktive peptide
DE69931482D1 (de) Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
DK0687180T3 (da) Fremgangsmåde til påvisning og behandling af individer, som har unormale celler, som udtrykker HLC-A2/tyrosinasepeptid-anti
IL193310A0 (en) Antibody directed against a polypeptide that interacts with parkin and pharmaceutical compositions comprising the same
ID23184A (id) Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi
DE59410423D1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
EP0717752A4 (de) Therapeitische inhaltsstoffe
DE69726602D1 (en) Hepatitis b inhibitoren
DZ2803A1 (fr) Polypeptide de la protéine c humaine.
DE59609353D1 (de) Mittel zur subkutanen Verabreichung von Protein C

Legal Events

Date Code Title Description
8364 No opposition during term of opposition